Clinical Trial Update: A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 confirmatory trial evaluating TAU-284 in pediatric patients with atopic dermatitis has completed, with the study results posted in October 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• TAU-284

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Dermatitis, Atopic | Phase 3 | Status: COMPLETED | Results posted: 2015-10-16